crizotinib Articles
IQWiG re-assessments come up with same view for saxagliptin and different for crizotinib
14 May 2013
Synta's ganetespib shows potency against ALK-positive lung cancer and overcomes crizotinib resistance
27 March 2013
Two Pfizer cancer drug candidates, crizotinib and bosutinib, accepted for filing in Europe
18 August 2011
Pfizer commences rolling FDA submission for lung cancer drug crizotinib; denies German VAT evasion
17 January 2011
ASCO highlights include cancer drug news from Pfizer, Roche, Sanofi, Merck KGaA, Novartis and Eisai
7 June 2010
Showing 1-9 of 9 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
